Literature DB >> 25481627

Rasagiline and Pisa syndrome in Parkinson's disease patients.

Paolo Solla1, Antonino Cannas, Gianni Orofino, Francesco Marrosu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25481627     DOI： 10.1007/s10072-014-2024-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.

Authors:  Alfonso Fasano; Alessandro Di Matteo; Carmine Vitale; Giovanna Squintani; Laura Ferigo; Federica Bombieri; Gabriella Santangelo; Marianna Amboni; Paolo Barone; Michele Tinazzi
Journal:  Mov Disord       Date:  2011-08-24       Impact factor: 10.338

2.  Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease.

Authors:  F Valentino; G Cosentino; B Fierro; S Realmuto; S Mastrilli; G Savettieri; M D'Amelio
Journal:  Neurol Sci       Date:  2014-04-27       Impact factor: 3.307

3.  Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient.

Authors:  Paolo Solla; Antonino Cannas; Socrate Congia; Gianluca Floris; Rosa Aste; Paolo Tacconi; Maria Giovanna Marrosu
Journal:  J Neurol Sci       Date:  2008-09-23       Impact factor: 3.181

4.  Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.

Authors:  Antonino Cannas; Paolo Solla; Gianluca Floris; Paolo Tacconi; Alessandra Serra; Mario Piga; Francesco Marrosu; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

5.  Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study.

Authors:  Michele Tinazzi; Ina Juergenson; Giovanna Squintani; Gaetano Vattemi; Stefania Montemezzi; Daniela Censi; Paolo Barone; Tommaso Bovi; Alfonso Fasano
Journal:  J Neurol       Date:  2013-05-22       Impact factor: 4.849
  5 in total
  2 in total

1.  Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease.

Authors:  F Valentino; G Cosentino; B Fierro; S Realmuto; S Mastrilli; G Savettieri; M D'Amelio
Journal:  Neurol Sci       Date:  2015-09-03       Impact factor: 3.307

2.  Movement disorders in emergency settings: a prospective study.

Authors:  Carlo Dallocchio; Angela Matinella; Carla Arbasino; Natale Arno'; Margaret Glorioso; Massimo Sciarretta; Massimiliano Braga; Michele Tinazzi
Journal:  Neurol Sci       Date:  2018-10-15       Impact factor: 3.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.